Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Monica Fedele, Orlando Paciello, Davide De Biase, Mario Monaco, Gennaro Chiappetta, Michela Vitiello, Antonio Barbieri, Domenica Rea, Antonio Luciano, Serenella Papparella, Claudio Arra & Alfredo Fusco. (2018) HMGA2 cooperates with either p27kip1 deficiency or Cdk4R24C mutation in pituitary tumorigenesis. Cell Cycle 17:5, pages 580-588.
Read now
Read now
Renata S. Auriemma, Ludovica F. S. Grasso, Rosario Pivonello & Annamaria Colao. (2016) The safety of treatments for prolactinomas. Expert Opinion on Drug Safety 15:4, pages 503-512.
Read now
Read now
Xin Zheng, Song Li, Wei-hua Zhang & Hui Yang. (2015) Metabolic abnormalities in pituitary adenoma patients: a novel therapeutic target and prognostic factor. Diabetes, Metabolic Syndrome and Obesity 8, pages 357-361.
Read now
Read now
Ludovica FS Grasso, Rosario Pivonello & Annamaria Colao. (2013) Investigational therapies for acromegaly. Expert Opinion on Investigational Drugs 22:8, pages 955-963.
Read now
Read now
Articles from other publishers (44)
Jianwu Wu, Songyuan Li, Yinxing Huang, Zihuan Zeng, Tao Mei, Shousen Wang, Wei Wang & Fangfang Zhang. (2023)
MRI
features of pituitary adenoma apoplexy and their relationship with hypoxia, proliferation, and pathology
. Journal of Clinical Ultrasound 51:6, pages 1078-1086.
Crossref
Crossref
Sérgio Portovedo, Leonardo Vieira Neto, Paula Soares, Denise Pires de Carvalho, Christina Maeda Takiya & Leandro Miranda-Alves. (2022) Aggressive nonfunctioning pituitary neuroendocrine tumors. Brain Tumor Pathology 39:4, pages 183-199.
Crossref
Crossref
Zahra Davoudi, Mohammad Hallajnejad, Elena Jamali & Mohammadjavad Honarvar. (2022) Aggressive prolactinomas responsive to temozolomide treatment: Report of two cases. Clinical Case Reports 10:7.
Crossref
Crossref
George Kontogeorgos, Eleni Thodou, Robert Y. Osamura & Ricardo V. Lloyd. (2022) High-risk pituitary adenomas and strategies for predicting response to treatment. Hormones 21:1, pages 1-14.
Crossref
Crossref
Kejing Zhu, Xueting Cheng, Shuman Wang, Hong Zhang, Yu Zhang, Xiong Wang, Yonggang Chen & Jinhu Wu. (2022) PBK/TOPK Inhibitor Suppresses the Progression of Prolactinomas. Frontiers in Endocrinology 12.
Crossref
Crossref
Halit Diri, Ersin Ozaslan, Ali Kurtsoy & Fahri Bayram. (2020) A single-center observational study assessing the predictive factors associated with the prognosis of acromegaly. Growth Hormone & IGF Research 55, pages 101342.
Crossref
Crossref
Pedro Iglesias, Rosa Magallón, Mercedes Mitjavila, Víctor Rodríguez Berrocal, Héctor Pian & Juan J. Díez. (2020) Multimodal therapy in aggressive pituitary tumors. Endocrinología, Diabetes y Nutrición 67:7, pages 469-485.
Crossref
Crossref
Pedro Iglesias, Rosa Magallón, Mercedes Mitjavila, Víctor Rodríguez Berrocal, Héctor Pian & Juan J. Díez. (2020) Multimodal therapy in aggressive pituitary tumors. Endocrinología, Diabetes y Nutrición (English ed.) 67:7, pages 469-485.
Crossref
Crossref
Fred Bteich, Lea El Khoury, Georges Nohra, Viviane Trak, Sandrine Yazbek & Mira Akiki. (2020) Pituitary Adenoma and Papillary Craniopharyngioma: A Rare Case of Collision Tumor and Review of the Literature. World Neurosurgery 139, pages 63-69.
Crossref
Crossref
Müjdat Kara, Fatma Tokat, M. Necmettin Pamir & Ayça Ersen Danyeli. (2020) Frequency and Role of CDKN2A Deletion in High-Risk Pituitary Neuroendocrine Tumors. Endocrine Pathology 31:2, pages 166-173.
Crossref
Crossref
Mariana Gomes-Porras, Jersy Cárdenas-Salas & Cristina Álvarez-Escolá. (2020) Somatostatin Analogs in Clinical Practice: A Review. International Journal of Molecular Sciences 21:5, pages 1682.
Crossref
Crossref
G. L. Kobyakov, I. V. Chernov, L. I. Astafieva, Yu. Yu. Trunin, A. A. Poddubsky & P. L. Kalinin. (2020) Use of chemotherapy in the treatment of aggresive pituitary adenomas. Voprosy neirokhirurgii imeni N.N. Burdenko 84:1, pages 69.
Crossref
Crossref
A. L. PappyIIII, A. Savinkina, C. Bicknese, S. Neill, N. M. Oyesiku & A. G. Ioachimescu. (2019) Predictive modeling for pituitary adenomas: single center experience in 501 consecutive patients. Pituitary 22:5, pages 520-531.
Crossref
Crossref
Congxin Dai, Xiaohai Liu, Sihai Ma, Ming Feng, Xinjie Bao, Kan Deng, Yong Yao, Renzhi Wang, DX. Feng, E. Fonkem, Frank Y. Shan & Jason H. Huang. 2019. Primary Intracranial Tumors. Primary Intracranial Tumors.
Dorota Dworakowska & Ashley B Grossman. (2018) Aggressive and malignant pituitary tumours: state-of-the-art. Endocrine-Related Cancer 25:11, pages R559-R575.
Crossref
Crossref
Gérald Raverot, Emmanuelle Dantony, Julie Beauvy, Alexandre Vasiljevic, Sara Mikolasek, Françoise Borson-Chazot, Emmanuel Jouanneau, Pascal Roy & Jacqueline Trouillas. (2017) Risk of Recurrence in Pituitary Neuroendocrine Tumors: A Prospective Study Using a Five-Tiered Classification. The Journal of Clinical Endocrinology & Metabolism 102:9, pages 3368-3374.
Crossref
Crossref
Bin Liu, Bo Pang, Qirui Wang, Shengji Yang, Taihong Gao, Qian Ding, Huajie Liu, Yihang Yang, Haitao Fan, Rui Zhang, Tao Xin, Guangming Xu & Qi Pang. (2017) EZH2 upregulation correlates with tumor invasiveness, proliferation, and angiogenesis in human pituitary adenomas. Human Pathology 66, pages 101-107.
Crossref
Crossref
Qilin Zhang, Cheng Peng, Jianping Song, Yichao Zhang, Jianhua Chen, Zhijian Song, Xuefei Shou, Zengyi Ma, Hong Peng, Xuemin Jian, Wenqiang He, Zhao Ye, Zhiqiang Li, Yongfei Wang, Hongying Ye, Zhaoyun Zhang, Ming Shen, Feng Tang, Hong Chen, Zhifeng Shi, Chunjui Chen, Zhengyuan Chen, Yue Shen, Ye Wang, Shaoyong Lu, Jian Zhang, Yiming Li, Shiqi Li, Ying Mao, Liangfu Zhou, Hai Yan, Yongyong Shi, Chuanxin Huang & Yao Zhao. (2017) Germline Mutations in CDH23, Encoding Cadherin-Related 23, Are Associated with Both Familial and Sporadic Pituitary Adenomas. The American Journal of Human Genetics 100:5, pages 817-823.
Crossref
Crossref
Congxin Dai, Bowen Sun, Xiaohai Liu, Xinjie Bao, Ming Feng, Yong Yao, Junji Wei, Kan Deng, Chengxian Yang, Xueyuan Li, Wenbin Ma & Renzhi Wang. (2017) O-6-Methylguanine-DNA methyltransferase expression is associated with pituitary adenoma tumor recurrence: a systematic meta-analysis. Oncotarget 8:12, pages 19674-19683.
Crossref
Crossref
Daniel A. Donoho, Namrata Bose, Gabriel Zada & John D. Carmichael. (2016) Management of aggressive growth hormone secreting pituitary adenomas. Pituitary 20:1, pages 169-178.
Crossref
Crossref
Stefano M. Priola, Felice Esposito, Salvatore Cannavò, Alfredo Conti, Rosaria V. Abbritti, Valeria Barresi, Sergio Baldari, Francesco Ferraù, Antonino Germanò, Francesco Tomasello & Filippo F. Angileri. (2017) Aggressive Pituitary Adenomas: The Dark Side of the Moon. World Neurosurgery 97, pages 140-155.
Crossref
Crossref
Congxin Dai, Ming Feng, Xiaohai Liu, Sihai Ma, Bowen Sun, Xinjie Bao, Yong Yao, Kan Deng, Yu Wang, Bing Xing, Wei Lian, Dingrong Zhong, Wenbin Ma & Renzhi Wang. (2016) Refractory pituitary adenoma: a novel classification for pituitary tumors. Oncotarget 7:50, pages 83657-83668.
Crossref
Crossref
Xin Zheng, Song Li, Weihua Zhang, Zhenle Zang, Jintao Hu & Hui Yang. (2016) Current biomarkers of invasive sporadic pituitary adenomas. Annales d'Endocrinologie 77:6, pages 658-667.
Crossref
Crossref
Xiaolei Lan, Hua Gao, Fei Wang, Jie Feng, Jiwei Bai, Peng Zhao, Lei Cao, Songbai Gui, Lei Gong & Yazhuo Zhang. (2016) Whole-exome sequencing identifies variants in invasive pituitary adenomas. Oncology Letters 12:4, pages 2319-2328.
Crossref
Crossref
RE Strowd, R Salvatori & JJ Laterra. (2015) Temozolomide retreatment in a recurrent prolactin-secreting pituitary adenoma: Hormonal and radiographic response. Journal of Oncology Pharmacy Practice 22:3, pages 517-522.
Crossref
Crossref
Xin Zheng, Song Li, Zhenle Zang, Jintao Hu, Jiayin An, Xiangdong Pei, Feng Zhu, Weihua Zhang & Hui Yang. (2016) Evidence for possible role of toll-like receptor 3 mediating virus-induced progression of pituitary adenomas. Molecular and Cellular Endocrinology 426, pages 22-32.
Crossref
Crossref
Christian P. Miermeister, Stephan Petersenn, Michael Buchfelder, Rudolf Fahlbusch, Dieter K. Lüdecke, Annett Hölsken, Markus Bergmann, Hans Ulrich Knappe, Volkmar H. Hans, Jörg Flitsch, Wolfgang Saeger & Rolf Buslei. (2015) Histological criteria for atypical pituitary adenomas – data from the German pituitary adenoma registry suggests modifications. Acta Neuropathologica Communications 3:1.
Crossref
Crossref
Luis V. Syro, Fabio Rotondo, Alex Ramirez, Antonio Di Ieva, Murat Aydin Sav, Lina M. Restrepo, Carlos A. Serna & Kalman Kovacs. (2015) Progress in the Diagnosis and Classification of Pituitary Adenomas. Frontiers in Endocrinology 6.
Crossref
Crossref
Zheng Chen, Zhenzhu Li, Yingwei Chang, Lixin Ma, Wenhu Xu, Meng Li, Jianmin Li, Wensheng Zhang, Qikai Sun, Xiaojing An & Zefu Li. (2015) Relationship between NF-κB, MMP-9, and MICA expression in pituitary adenomas reveals a new mechanism of pituitary adenomas immune escape. Neuroscience Letters 597, pages 77-83.
Crossref
Crossref
James K. Liu, Jimmy Patel & Jean Anderson Eloy. (2015) The role of temozolomide in the treatment of aggressive pituitary tumors. Journal of Clinical Neuroscience 22:6, pages 923-929.
Crossref
Crossref
Misu Lee, Amelie Lupp, Nigel Mendoza, Niamh Martin, Rudi Beschorner, Jürgen Honegger, Jürgen Schlegel, Talia Shively, Elke Pulz, Stefan Schulz, Federico Roncaroli & Natalia S Pellegata. (2015) SSTR3 is a putative target for the medical treatment of gonadotroph adenomas of the pituitary. Endocrine-Related Cancer 22:1, pages 111-119.
Crossref
Crossref
Oscar D. Bruno, Lea Juárez-Allen, Silvia B. Christiansen, Marcos Manavela, Karina Danilowicz, Carlos Vigovich & Reynaldo M. Gómez. (2015) Temozolomide Therapy for Aggressive Pituitary Tumors: Results in a Small Series of Patients from Argentina. International Journal of Endocrinology 2015, pages 1-8.
Crossref
Crossref
Javier Aller Pardo, Mariana Campderá Michelena, Nuria Palacios García & Javier Estrada García. 2015. Actualización en neuroendocrinología. Actualización en neuroendocrinología
171
198
.
Jillian Maclean, Matthew Aldridge, Jamshed Bomanji, Susan Short & Naomi Fersht. (2013) Peptide receptor radionuclide therapy for aggressive atypical pituitary adenoma/carcinoma: variable clinical response in preliminary evaluation. Pituitary 17:6, pages 530-538.
Crossref
Crossref
Antonio Di Ieva, Fabio Rotondo, Luis V. Syro, Michael D. Cusimano & Kalman Kovacs. (2014) Aggressive pituitary adenomas—diagnosis and emerging treatments. Nature Reviews Endocrinology 10:7, pages 423-435.
Crossref
Crossref
Carmen A. Carrasco, Mônica Gadelha, Marcos Manavela & Oscar D. Bruno. (2013) Aggressive tumors and difficult choices in acromegaly. Pituitary 17:S1, pages 24-29.
Crossref
Crossref
Congxin Dai, Bo Zhang, Xiaohai Liu, Kai Guo, Sihai Ma, Feng Cai, Yakun Yang, Yong Yao, Ming Feng, Xinjie Bao, Kan Deng, Yonghui Jiao, Zhenqing Wei, Wei Junji, Bing Xing, Wei Lian & Renzhi Wang. (2013) Pyrimethamine sensitizes pituitary adenomas cells to temozolomide through cathepsin B-dependent and caspase-dependent apoptotic pathways. International Journal of Cancer 133:8, pages 1982-1993.
Crossref
Crossref
Xianzhen Chen, Fei Xue, Tianhao Xie & Chun Luo. (2013) RETRACTED ARTICLE: Silencing of the Smad nuclear interacting protein 1 (SNIP1) by siRNA inhibits proliferation and induces apoptosis in pituitary adenoma cells. Tumor Biology 34:5, pages 3071-3076.
Crossref
Crossref
Congxin Dai, Bo Zhang, Xiaohai Liu, Sihai Ma, Yakun Yang, Yong Yao, Ming Feng, Xinjie Bao, Guilin Li, Janxin Wang, Kai Guo, Wenbin Ma, Bing Xing, Wei Lian, Jianqi Xiao, Feng Cai, Hongbin Zhang & Renzhi Wang. (2013) Inhibition of PI3K/AKT/mTOR Pathway Enhances Temozolomide-Induced Cytotoxicity in Pituitary Adenoma Cell Lines in Vitro and Xenografted Pituitary Adenoma in Female Nude Mice. Endocrinology 154:3, pages 1247-1259.
Crossref
Crossref
CongXin Dai, Feng Cai, Kuo Chu Hwang, YongMao Zhou, ZiZhu Zhang, XiaoHai Liu, SiHai Ma, YaKun Yang, Yong Yao, Ming Feng, XinJie Bao, GuiLin Li, JunJi Wei, YongHui Jiao, ZhenQing Wei, WenBin Ma & RenZhi Wang. (2013) Folate receptor-mediated boron-10 containing carbon nanoparticles as potential delivery vehicles for boron neutron capture therapy of nonfunctional pituitary adenomas. Science China Life Sciences 56:2, pages 163-173.
Crossref
Crossref
Ozgur Mete, Shereen Ezzat & Sylvia L Asa. (2012) Biomarkers of aggressive pituitary adenomas. Journal of Molecular Endocrinology 49:2, pages R69-R78.
Crossref
Crossref
Brandon A. Miller, W. Caleb Rutledge, Adriana G. Ioachimescu & Nelson M. Oyesiku. (2012) Management of Large Aggressive Nonfunctional Pituitary Tumors. Neurosurgery Clinics of North America 23:4, pages 587-594.
Crossref
Crossref
. (2012) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 19:4, pages 328-337.
Crossref
Crossref
Beatriz Gómez-González, Emilio Domínguez-Salazar, Gabriela Hurtado-Alvarado, Enrique Esqueda-Leon, Rafael Santana-Miranda, Jose Angel Rojas-Zamorano & Javier Velázquez-Moctezuma. (2012) Role of sleep in the regulation of the immune system and the pituitary hormones. Annals of the New York Academy of Sciences 1261:1, pages 97-106.
Crossref
Crossref